Internet and Psychiatry
  • Home
    • Editorials
    • Research news
    • Research papers
    • Interviews with eminent psychiatrists
    • Ten years ago
    • Fifteen years ago
  • Topics
    • Alcohol and Drug Abuse
    • Anxiety Disorders
    • Biomedical Science
    • Compulsive gambling
    • Disaster Medicine
    • Education
    • General Medicine
      • Acupuncture
      • Physical medicine and Rehabilitation
    • Human Rights
    • Interviews with eminent psychiatrists
    • Mood Disorders
      • Bipolar Disorder
      • Depression
      • Seasonal Affective Disorder
    • Neurological Disorders
    • Other Psychiatric Disorders
    • Posttraumatic Stress Disorder
    • Sexual Behavior
  • Books
    • Comorbidity of Depression and Alcohol Use Disorders
    • “Immigration and Mental Health” chapter abstracts
    • “Internet and Suicide” chapter abstracts
    • “Neurobiology of PTSD” chapter abstracts
    • “Suicidal Behavior in Alcohol…” chapter abstracts
    • “Suicide in the Military” chapter abstracts
    • “Terror and Suicide” chapter abstracts
    • “War and Suicide” chapter abstracts
  • Editors
    • Leo Sher, M.D.
    • Alexander Vilens, M.S.
  • Guests
    • Distinguished Guests
    • Our Contributors
  • Reflections
    • Poetry
    • Quotes

Fifteen years ago

Cerebrospinal fluid monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol use disorder

January 5, 2022

Leo Sher, M.D.

Our research paper, “CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence” was published 15 years ago in the January 2007 issue of European Neuropsychopharmacology (1). In this study, we investigated the relationship of cerebrospinal fluid (CSF) 5-hydroxyindolacetic acid (5-HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxyphenylglycol (MHPG) levels to lethality of suicide attempts in drug free patients with comorbid alcoholism and major depression.

All subjects met DSM-IV criteria for a current major depressive episode, alcohol dependence and had made a previous suicide attempt. Participants were free from medications known to affect brain serotonin, dopamine, or norepinephrine systems for a minimum of 14 days. The drug-free interval was longer for drugs with a long half-life (6 weeks for fluoxetine and 4 weeks for oral antipsychotics).The Beck Lethality Scale was used to evaluate degree of medical damage. Study participants with medical lethality scores ≥4 were classified as high-lethality suicide attempters, participants with medical lethality scores <4 were regarded as low-lethality attempters. The classification between low-lethality and high-lethality attempters was based on lifetime history.

There were 16 low-and 16 high-lethality suicide attempters. There was no difference between the two groups with regard to the demographic characteristics or psychiatric measures. We found that CSF 5-HIAA levels were lower in high-lethality attempters compared to low-lethality attempters. There were no group differences in the CSF HVA or MHPG levels. Controlling for age and gender did not change the results for CSF 5-HIAA. The difference in the CSF HVA and CSF MHPG levels remained non-significant after the adjustment for age and gender. The results of this study indicate that lethality of suicidal behavior in depressed patients with alcoholism is related to serotonergic activity.

Reference

  1. Sher L, Oquendo MA, Grunebaum MF, Burke AK, Huang YY, Mann JJ. CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence. Eur Neuropsychopharmacol. 2007 Jan;17(1):12-5. doi: 10.1016/j.euroneuro.2006.04.011. Epub 2006 Jun 8.

Related Posts

Fifteen years ago /

First episode polarity and risk for suicide attempt in bipolar disorder

Fifteen years ago /

A study of brain metabolic responses to a serotonergic challenge in major depression with or without comorbid alcohol dependence

Fifteen years ago /

Suicidal behavior in depressed older adolescents and young adults with or without comorbid alcohol use disorder

‹ Omicron spread and oral antiviral pills are big news. The advent of nirmatrelvir and ritonavir: called Paxlovid › The World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Men’s Mental Health – January 2022 update

Editorials

  • Suicide medical malpractice
  • Dr. Slavko Ziherl, an eminent Slovenian psychiatrist
  • Prevention of suicidal behavior in individuals with diabetes
  • National Respect Day

Research Papers

  • COVID-19 mortality in Europe and the ’Iron Curtain’ between East and West
  • Examination of depressive signs and symptoms among 803 University students in seven Universities and Colleges. Hungary, Romania, Serbia.
  • Examination of spirituality and the dimensions of spirituality among 803 students in seven different Universities. Hungary, Romania and Serbia.
  • Examination of depressive signs and symptoms among 932 students in eight different secondary schools in Hungary

Research News

  • Mortality in patients with schizophrenia: a review and meta-analysis
  • Long COVID, psychiatric disorders and suicidality
  • Mortality rates for buprenorphine versus methadone treatments
  • Brain-derived neurotrophic factor levels in combat veterans with or without a history of suicide attempt

Latest News

  • Best universities in the world
  • Geriatric Psychiatry Fellowship
  • 2022 National Veteran Suicide Prevention Annual Report
  • Long COVID and suicide

Interviews with eminent psychiatrists

  • Interview with Professor Shih-Ku Lin
  • Interview with Professor Masahito Fushimi
  • Interview with Professor Maurizio Pompili
  • Interview with Professor Marco Sarchiapone

Ten Years Ago

  • Plasma testosterone levels in bipolar suicide attempters
  • Teaching medical professionals and trainees about suicide prevention
  • Suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors
  • Treatment of suicide attempters with bipolar disorder: a randomized clinical trial

Back to Top

  • About
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2022 AVCalc LLC. All rights reserved worldwide.